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Abstract
In Saccharomyces cerevisiae, the conserved phosphatase Cdc14 is required for the exit from mitosis. It is anchored on
nucleolar chromatin by the Cfi1/Net1 protein until early anaphase, at which time it is released into the nucleoplasm. Two
poorly understood, redundant pathways promote Cdc14 release, the FEAR (Cdc fourteen early release) network and the
MEN (mitotic exit network). Through the analysis of genetic interactions, we report here a novel requirement for the
ubiquitination of histone H2B by the Bre1 ubiquitin ligase in the cell cycle–dependent release of Cdc14 from nucleolar
chromatin when the MEN is inactivated. This function for H2B ubiquitination is mediated by its activation of histone H3
methylation on lysines 4 and 79 (meH3K4 and meH3K79) but, surprisingly, is not dependent on the histone deacetylase
(HDAC) Sir2, which associates with Cdc14 on nucleolar chromatin as part of the RENT complex. We also observed a defect in
Cdc14 release in cells lacking H3 lysine 36 methylation (meH3K36) and in cells lacking an HDAC recruited by this
modification. These histone modifications represent previously unappreciated factors required for the accessibility to and/or
action on nucleolar chromatin of FEAR network components. The nonredundant role for these modifications in this context
contrasts with the notion of a highly combinatorial code by which histone marks act to control biological processes.
Citation: Hwang WW, Madhani HD (2009) Nonredundant Requirement for Multiple Histone Modifications for the Early Anaphase Release of the Mitotic Exit
Regulator Cdc14 from Nucleolar Chromatin. PLoS Genet 5(8): e1000588. doi:10.1371/journal.pgen.1000588
Editor: Asifa Akhtar, European Molecular Biology Laboratory, Germany
Received November 20, 2008; Accepted July 7, 2009; Published August 7, 2009
Copyright:  2009 Hwang, Madhani. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Supported by NIH grant 5R01GM071801 to HDM. HDM is a scholar of the Leukemia and Lymphoma Society. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hitenmadhani@gmail.com
Introduction
To ensure the timely and correct inheritance of sister chromatids
followed by cytokinesis, eukaryotic cells have evolved sophisticated
regulatory networks. Part of the regulatory complexity involves the
requirement that a variety of soluble proteins communicate with
tightly chromatin-bound factors on chromosomes. An example of
such a mechanism in the budding yeast S. cerevisiae is the control of
Cdc14, a conserved and essential protein phosphatase. Outside of
anaphase, Cdc14 is kept away from its soluble substrates by being
tightly associated withnucleolarchromatinthroughitsinhibitor,the
nucleolar protein Cfi1/Net1. Upon entry into anaphase, however,
this interaction is dissolved via the phosphorylation of Cfi/Net1,
which isnecessaryforthe releaseofCdc14from thenucleolus[1–3].
Liberated Cdc14 dephosphorylates mitotic Clb cyclin dependent
kinases (Clb-CDKs) and their substrates to promote exit from
mitosis [3–6].
Work in the last decade has elucidated two pathways, dubbed
the FEAR (Cdc Fourteen Early Anaphase Release) network and
the MEN (Mitotic Exit Network), that together control the release
of Cdc14 [7,8]. The MEN, the first and better characterized of the
two networks, is a signaling cascade which is controlled by the
GTPase Tem1 and its upstream regulators, the GTPase activating
complex Bub2-Bfa1 and the GTP exchange factor Lte1. Before
and during early anaphase, Tem1 is kept in its inactive GDP state
by association with Bub2-Bfa1 at the spindle pole body (SPB). As
the SPB enters the daughter cell during mid to late anaphase,
Tem1 is relieved of inhibition by exposure to bud localized Lte1
and activates a kinase cascade consisting of Cdc15 and the Dbf2/
Mob1 complex [9–14]. Finally, through an uncharacterized
mechanism, Dbf2/Mob1 directs the release of Cdc14, possibly
through direct phosphorylation of Cfi1/Net1 [14].
MEN mutants, however, still display a transient release of Cdc14
early in anaphase [15–18]. This observation led to the identification
of the FEAR network, encoded by a set of genes that when mutated
in combination with mutations in the MEN are unable to release
Cdc14 from the nucleolus [16]. Genetic epistasis experiments
separate FEAR network components into two pathways [19]. One
is regulated by a non-proteolytic function of Esp1, the cohesin
protease also known as separase, which acts in concert with the
kinetochore associated protein Slk19 to inhibit the paralogs Zds1
and Zds2 [16,18,20]. These latter proteins appear to inhibit a type
2A protein phosphatase called PP2A
Cdc55 that otherwise reverses
the phosphorylationof Cfi1/Net1 by Clb-CDK [20]. The anaphase
inactivation of PP2A
Cdc55 has been suggested to lead to the
accumulation of phosphorylated, inactive Cfi1/Net1 and conse-
quent release of Cdc14 [21]. The second branch of the FEAR
network includes the nucleolar protein Spo12, its homolog Bns1,
and Fob1, which binds Spo12 to relieve its inhibitory interaction
with Cfi1/Net1 [16,19,22,23]. The initial burst of Cdc14 release
promotedbytheFEARnetworkfeedsforwardtoactivatetheMEN,
thus promoting its continued release until the end of mitosis
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Cdc5, which can regulate the MEN by inhibition of the Bub2/Bfa1
complex but is also required for FEAR network mediated Cdc14
release downstream of or parallel to separase by potential direct
phosphorylation of Net1 [1,16,19,26,27] (Figure 1). The biochem-
ical mechanisms by which FEAR network components combine to
regulate early anaphase release of Cdc14 remain a mystery.
Cfi1/Net1, in addition to regulating Cdc14 function, is localized
onto rDNA chromatin with the histone deacetylase Sir2 in a
protein complex named RENT (regulator of nucleolar silencing
and telophase exit) to regulate the silencing of rDNA heterochro-
matin, recombination of the rDNA repeats, and RNA Polymerase
I transcription [5,6,28–30]. The localization of RENT to the
NTS1 (non-transcribed spacer) region of rDNA is dependent on
Fob1, which also has multiple functions at this region including
blocking replication fork progression to prevent the collision of
convergent DNA polymerases [30]. Curiously, Cdc14 is seques-
tered on rDNA chromatin specifically at this RFB (replication fork
block) along with the other members of the RENT complex and
Fob1, leading to speculation on whether or not the regulation for
these other activities at rDNA overlap with the regulation of
Cdc14 release [23,30].
Recent studies have revealed a role for histone modifications in
regulating rDNA functions. In particular, the methylation of
histone H3 on Lysine 4 and 79 by the methyltransferases Set1 and
Dot1 respectively are required for robust rDNA silencing [31–35].
These modifications require the presence of monoubiquitination
on Lysine 123 of histone H2B (ubH2B-K123), mediated by the E2
ubiquitin conjugating enzyme Rad6 and the E3 ubiquitin ligase
Bre1 [36–38]. Deletion of the H2B deubiquitinating enzyme
Ubp10 results in decreased Sir2 association at rDNA and
increased the recombination frequency of rDNA repeats [39],
suggesting that histone modifications can play a direct role in
regulating rDNA functions.
Based on recent genetic evidence from large-scale synthetic
lethal screens linking the histone ubiquitination machinery to
members of the MEN [40,41], we investigated the possibility that
histone modifications may be required for efficient exit from
mitosis. We verified the genetic interactions cited above and
demonstrate a requirement for histone ubiquitination in the early
nucleolar release of Cdc14 during early anaphase in the absence of
Figure 1. Regulation of Cdc14 release by the MEN and FEAR network. See Introduction for description.
doi:10.1371/journal.pgen.1000588.g001
Author Summary
During proliferation, eukaryotic cells segregate their
replicated genome to generate two identical progeny
through a highly regulated process called mitosis.
Inaccuracy in this process results in cell inviability or
aneuploidy. In the S. cerevisiae cell cycle, the exit from the
mitotic state is triggered by the release of the phosphatase
Cdc14 during the anaphase stage of mitosis from nucleolar
chromatin, where it is sequestered and kept inactive. The
role of chromatin, if any, in the regulation of Cdc14
sequestration and/or release is unexplored. Using genetic
analysis, we have discovered that multiple evolutionarily
conserved histone modifications are required for the early
anaphase release of Cdc14. These include monoubiquiti-
nation of histone H2B as well as two methylations of
histone H3 on lysines 4 and 79 that require H2B
monoubiquitination to occur efficiently. In addition,
methylation of H3 on lysine 36 and a histone deacetylase
recruited by this modification are also required. We
suggest that these histone modifications are required on
nucleolar chromatin for the accessibility and/or action of
factors involved in the early anaphase release of Cdc14.
The nonredundant requirement for multiple chromatin
modifications stands in contrast to the popular notion of a
highly combinatorial ‘‘histone code’’ for the action of
histone modifications.
Histone Modifications Required for Cdc14 Release
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histone methylation by ubH2B-K123 but is independent of Sir2.
Finally, we show that these effects are not due to aberrant
regulation of known FEAR network components and can be
extended to other histone modifications.
Results
H2B-K123 Ubiquitination Is Required for Cell Viability and
Full Release of Cdc14 from the Nucleolus When MEN Is
Inactive
We reasoned that new functions for Bre1, the conserved
ubiquitin ligase for ubH2B-K123, might be illuminated through
the identification of mutants that display synthetic growth defects
when combined with bre1D mutants. High-throughput microarray-
based studies reported a genetic interaction between bre1D and
deletion of the GTP exchange factor Lte1, a regulator of the MEN
[40,41]. Such a genetic interaction is characteristic for members of
the FEAR network, which act in a partially redundant manner
with the MEN to regulate the essential release of Cdc14 from the
nucleolus and promote exit from mitosis (Figure 1). Specifically,
defects in the MEN render FEAR network components essential
for viability and is a defining characteristic of FEAR members
[16]. Therefore, we investigated the possible requirement for Bre1
in the release of Cdc14 in early anaphase. We confirmed the
reported synthetic interaction and observed the inviability of the
bre1D lte1D double mutant as determined by its inability to lose a
URA3-marked plasmid encoding LTE1 as assayed by lack of
growth on 5-FOA media (Figure 2A). The lethal phenotype of the
bre1D lte1D mutant was rescued by the deletion of BUB2,a n
upstream negative regulator of the MEN, consistent with the
notion that lethality of the bre1D lte1D mutant results from a defect
in mitotic exit (Figure S1). Synthetic lethality was also observed in
double mutants containing a deletion of LTE1 with either RAD6,
which encodes the E2 enzyme for H2B ubiquitination, or LGE1,
which encodes a Bre1-interacting protein that is required for
ubH2B-K123 (Figure S1).
Since histone H2B is the only known substrate for Bre1, we
hypothesized that ubH2B-K123 mediates the mitotic exit
functions for Bre1. To test this hypothesis, we generated a strain
replacing the codon for lysine 123 of both histone H2B genes with
one coding for arginine (htb1-K123R htb2-K123R), rendering
histone H2B unable to be ubiquitinated. We first examined the
phenotype of a triple mutant with lte1D. The htb1-K123R htb2-
K123R lte1D triple mutant displayed a very severe growth defect
(Figure 2A). This result points to a role for ubH2B-K123 as the
downstream effector of Bre1 in promoting mitotic exit. However,
the ability to obtain viable, albeit very slow, colony growth for the
triple mutant compared to the inviability of the bre1D lte1D mutant
is consistent with an additional function for Bre1 that is
independent of H2B ubiquitination.
To test more directly the potential roles of Bre1 and ubH2B-
K123 in FEAR network function, we took advantage of the
observation that cells synchronized for cell cycle progression (by
arrest in G1 with mating pheromone followed by release into the
cell cycle) transiently release Cdc14 (as determined by indirect
immunofluorescence) during early anaphase when the MEN was
inactivated by the cdc15-2 mutation. In this MEN mutant
background, Slk19 and Spo12 have been reported to be required
for full release of Cdc14 [16]. In our experiments, cdc15-2 mad1D
slk19D mutants (MAD1 is deleted to allow comparison to slk19D
mutants, which exhibit spindle checkpoint defects [42]) displayed a
complete defect in Cdc14 release during anaphase, while cdc15-2
mad1D spo12D bns1D mutants displayed a small population with a
partial release phenotype, characterized by Cdc14 release
combined with residual sequestration in the nucleolus (Figure 2B
and 2C). This is consistent with the published phenotypes of
FEAR mutants [16]. When cdc15-2 mad1D bre1D mutants were
assayed, they showed a defect in Cdc14 release during early
anaphase reminiscent of cdc15-2 mad1D spo12D bns1D mutants.
Similarly, cdc15-2 mad1D htb1-K123R htb2-K123R quadruple
mutants were also unable to fully release Cdc14 (Figure 2C).
To ensure that the Cdc14 release phenotypes we observed were
not the result of asynchronous release from arrest resulting in the
imprecise measurement of anaphase, we assayed for Cdc14 release
phenotypes in individual cells while measuring spindle lengths as a
moreprecisemarker ofanaphase progression. We observe full release
of Cdc14 in a high percentage of cdc15-2 mad1D cells with short
spindles (2–6 mm), while cdc15-2 mad1D bre1D mutants only display a
small percentage of Cdc14 that is partially released, in accordance
with our timecourse results (Figure S2). In addition, we observed that
cdc15-2 mad1D bre1D and cdc15-2 mad1D htb1-K123R htb2-K123R
mutantsdisplayeda,40 minutedelayinprogressionintometaphase
and anaphase. This defect in cdc15-2 mad1D bre1D mutants was a
result of a prior cell cycle delay of ,30–40 minutes that occurs prior
to G2, as demonstrated by the analysis of DNA content and most
likely does not reflect a defect in mitotic entry (Figure S3).
Another defining characteristic of FEAR network mutants is
that they are delayed in cell cycle progression due to the
elongation of anaphase [16]. To test whether or not bre1D mutants
display this defect, we measured the progression through the cell
cycle of synchronized mad1D, mad1D bre1D, and mad1D slk19D
mutant cells. mad1D bre1D mutants, like mad1D slk19D mutants,
exhibited a 10 minute increase in time spent in anaphase when
compared to mad1D mutants (,50 minutes total time in anaphase
for mad1D mutants vs. ,60 minutes for mad1D bre1D or mad1D
slk19D mutants) (Figure 2D).
Cdc14 Release Defects Observed in bre1D Cannot Be
Explained by Alterations in Expression and Localization of
FEAR Network Members
Several studies, including our own, have established transcrip-
tional changes in the bre1D mutant and mutants in H2B
ubiquitination (our unpublished observations), [43]. It is possible
that the defects we observe for Cdc14 release in bre1D are due to
transcriptional changes of genes encoding for known regulators of
mitotic exit. To address this possibility, we measured the mRNA
levels of known MEN and FEAR network regulators by reverse
transcription coupled to quantitative PCR analysis (RT-QPCR).
We observed no significant changes in transcript levels between
wildtype and bre1D mutants (Figure 3A). In addition, we epitope-
tagged several key FEAR network components and compared their
protein expression levels in wild type cells to bre1D mutants to
account for any post-transcriptional regulation of these proteins
(Figure 3B). Levels of the Cdc14 release activators Slk19, Spo12,
and Cdc15 would be expected to decrease in bre1D mutants if
expression changes were the cause of the mitotic exit defects
observed for histone H2B ubiquitination mutants. We observed no
decreases in these activators; in fact, we found that the levels of
Slk19 are increased in bre1D cells (Figure 3B). Conversely, inhibitors
of Cdc14 release such as Fob1, Cfi/Net1, and the PP2A regulatory
subunits Cdc55 and Tpd3, would be increased in expression to
explain the Cdc14 release defects in bre1D mutants. We observed no
changesinbre1D mutantsfortheinhibitorslistedabove exceptCfi1/
Net1, which displays an increase in expression (Figure 3B).
This increase in Cfi1/Net1 levels provided a possible explana-
tion for the mitotic exit defects observed for bre1D mutants that we
sought to investigate further. Cdc14 sequestration in nucleolar
Histone Modifications Required for Cdc14 Release
PLoS Genetics | www.plosgenetics.org 3 August 2009 | Volume 5 | Issue 8 | e1000588Figure 2. Mutants unable to ubiquitinate histone H2B-K123 display growth and Cdc14 release defects when combined with MEN
mutants. (A) Genetic interaction of the bre1D and htb1-K123R htb2-K123R mutations with the lte1D mutation. Shown is the growth on 5-FOA and SD
–Ura minimal media of five-fold serial dilutions of strains of the indicated genotype that initially harbored an URA3-marked centromeric plasmid
encoding LTE1. Plates were incubated for 3 days at 30uC. See Materials and Methods for details. (B) Representative images from Cdc14 release assay.
Cells are assayed for spindle morphology and Cdc14 release phenotype by indirect immunofluorescence with anti-tubulin or anti-HA, which
recognizes the HA-tagged version of Cdc14 in all strains. Cells are visualized by nuclear staining with 49,6-diamidino-2-phenylindole (DAPI) and by
differential interference contrast (DIC) optics for comparison. No release refers to dense nucleolar staining of Cdc14-HA, full release refers to cells with
uniform Cdc14-HA localization throughout the nucleus, while partial release refers to cells with both nuclear and residual nucleolar staining. (C) Time
course analysis. The temporal profile of Cdc14 release from nucleolar sequestration is displayed for cdc15-2 mad1D mutants harboring either no
additional mutation, bre1D, htb1-K123R htb2-K123R,o rspo12D bns1D mutations. Alpha-factor arrested cells are released into YPD media at 37uCt o
inactivate the cdc15-2 mutant gene product and timepoints are processed for indirect immunofluorescence as described in Figure 2B. Approximately
200 cells were scored for each timepoint for metaphase or anaphase spindles and for full or partial release of Cdc14-HA. (D) Time course analysis. Cell
cycle progression of mad1D, mad1D bre1D, and mad1D slk19D mutants arrested and released from alpha-factor arrest was measured by scoring ,200
cells from each timepoint for anaphase spindles by indirect immunofluorescence.
doi:10.1371/journal.pgen.1000588.g002
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which interact biochemically and co-localize to the NTS1 region
of rDNA along with Cdc14 [23,30]. If the increase in total Cfi1/
Net1 levels corresponds to an increase in Cfi1/Net1 occupancy at
NTS1 in bre1D mutants, Cdc14 sequestration could be increased,
causing the observed Cdc14 release defects. Furthermore, even
though total Fob1 levels are unchanged in bre1D mutants, Fob1
bound to chromatin could in principle be increased by a loss of
uH2B-K123, leading to defects in mitotic exit similar to those
observed previously for strains overexpressing Fob1 [23]. To test
these possibilities, the quantitative association of epitope-tagged
Cfi1/Net1 and Fob1 to the rDNA loci was measured by
chromatin immunoprecipitation (ChIP) in wild type and bre1D
strains. We observed enrichment of Cfi1/Net1 and Fob1 at the
Figure 3. Changes in expression and chromatin association of mitotic exit regulators do not explain Cdc14 release defects in bre1D
mutants. (A) Reverse transcription coupled to quantitative PCR analysis (RT–QPCR) of known mitotic exit regulators. Levels of cDNA generated from
RT reactions of wildtype and bre1D total RNA were measured by QPCR. The mean values and standard deviations presented represent triplicate
samples for each strain and are normalized to ACT1 levels. Reactions were performed without RT (2RT) to establish background DNA contamination.
BFA1, the lowest level transcript, was enriched 15 fold over the 2RT control (data not shown). (B) Western blots of epitope-tagged regulators of
Cdc14 release. Cdc15, Fob1, Cfi1/Net1, Tpd3 and Cdc55 were tagged with 3xHA while Slk19 and Spo12 were tagged with 4xmyc and 13xmyc,
respectively. The blots were cut into two parts to simultaneously probe for the epitope tag on the upper part and with anti-dimeH3K4 on the lower
to demonstrate loss of BRE1. The upper blots were stripped and reprobed with anti-Pgk1 to control for loading. (C) Chromatin immunoprecipitation
of HA tagged Cdc14, 3xHA tagged Cfi1/Net1, and 3xHA tagged Fob1 in wild type and bre1D mutant backgrounds. The numbers on the x-axis refer to
primer pairs used to amplify the immunoprecipitated samples corresponding to locations at the rDNA locus as depicted in the schematic below and
from [62]. Quantitative PCR mean values and standard deviations presented represent triplicate samples for each rDNA primer set and are normalized
to values from a control primer set located within the open reading frame (ORF) of BUD3. Dotted lines separate the primer pairs corresponding to
different regions of the rDNA locus. Bottom panel: NTS 1 and 2=non-transcribed spacer regions 1 and 2. RFB=replication fork block. 5S, 5.8S, 18S,
25S=rDNA open reading frames.
doi:10.1371/journal.pgen.1000588.g003
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not detect any significant changes in bre1D mutants (Figure 3B).
Thus, the mitotic exit defects of bre1D mutants cannot be
explained by detectable changes in the localization profiles of
known chromatin-associated Cdc14 regulators. Finally, it is
possible that the excess Cfi1/Net1 observed in bre1D cells could
be aberrantly sequestering Cdc14 elsewhere in the nucleolus,
rendering Cdc14 inaccessible to activation by the FEAR network.
To address this possibility, we measured Cdc14 levels at rDNA by
ChIP. We observed no significant alteration of the Cdc14 signal at
these endogenous sites of sequestration.
Cdc14 Release Defects of Cells Defective for ubH2B-K123
Can Be Explained by Defects in Downstream Methylation
of Histone H3
To date, the only characterized role for H2B ubiquitination is to
promote the downstream methylation of H3K4 and H3K79.
Therefore we tested the hypothesis that the Cdc14 release defects
we observed in bre1D and htb1-K123R htb2-K123R strains were due to
the absence of meH3K4 and/or meH3K79. We first assayed the
phenotype of double mutants of lte1D and deletions of Set1 and Dot1,
the methyltransferases responsible for meH3K4 and meH3K79,
respectively. The lte1D set1D mutant displayed a synthetic lethal
phenotype while the lte1D dot1D mutant exhibited a similar growth
defecttothelte1Dsingle mutant (Figure 4A). This phenotype for set1D
is unaffected by the loss of Dot1, as the set1D dot1D lte1D triplemutant
is also inviable (Figure 4A). This genetic data suggested that the
requirement for H2B ubiquitination in mitotic exit might be specific
to its downstream activation of meH3K4.
To test this prediction directly, we assayed for the early anaphase
Cdc14 release incdc15-2mad1D strains containingdeletionsofSET1
and DOT1 (Figure 4B). The cdc15-2 mad1D set1D mutant was unable
to release Cdc14, consistent with the genetic interaction between
set1D and lte1D and similar to the phenotype we observed for bre1D
and htb1-K123R htb2-K123R mutants. However, in contrast the
predictions from the genetic interactions, cdc15-2 mad1D dot1D
mutants are also unable to fully release Cdc14, though the release
defect is milder than that observed for set1D mutants. This
discrepancy may be explained by differing thresholds for function
in the two assays and/or the fact that eliminating the function of
Cdc15,thecentraland essentialkinaseoftheMEN,isa more severe
perturbation of mitotic exit than the deletion of the non-essential
upstream regulator Lte1. In addition, the defect in Cdc14 release of
the methylase mutants is due to their primary function in histone
methylation, as unmethylatable lysine to arginine mutants of H3K4
and H3K79 (H3K4R and H3K79R) were also unable to efficiently
release Cdc14 (Figure 4C). We note that set1D mutants exhibited a
more severe Cdc14 release defect compared to the H3K4R mutant.
This is potentially explained by the loss, in set1D mutants, of the
Set1-dependent methylation of the kinetochore protein Dam1 or
other unknown targets [44]. Taken together, the genetic and Cdc14
release data suggests that the loss of methylation on H3K4 and
H3K79 are required for efficient release of Cdc14 in the absence of
MEN, suggesting a more generalized requirement for histone
modifications in this process.
Cdc14 Release in the Absence of MEN Activity Requires
the Methylation of meH3K36 and Its Recruited Histone
Deacetylase Rpd3
Our data suggest that in the absence of MEN activity, multiple
histone H3 methylation events are required for the complete
release of Cdc14 from sequestration. To address the specificity of
this requirement, we assayed the phenotype of double mutants of
lte1D and deletion of Set2, the remaining histone H3 methylase in
yeast, which catalyzes the modification of lysine 36. Surprisingly,
the lte1D set2D double mutant displayed a slight synthetic sick
phenotype, suggesting a potential role for meH3K36 in promoting
mitotic exit (Figure 4A). This was confirmed by examination of the
Cdc14 release profile of a cdc15-2 mad1D strain carrying a deletion
of Set2 or an unmethylatable lysine to arginine mutation of
H3K36 (H3K36R). These mutants also displayed a defect in
Cdc14 release that was similar to the defect observed in mutants
unable to methylate H3K4 and H3K79 (Figure 4B and 4C).
The requirement for meH3K36 for efficient Cdc14 release is
intriguing because this methylation has been demonstrated to
recruit the Rpd3 histone deacetylase complex. Large-scale screens
have detected a synthetic lethal interaction between lte1D and
rpd3D mutants [40], which we reconfirmed using our plasmid
shuffle strategy (Figure 5A) raising the possibility that histone
deacetylation by Rpd3 is an additional requirement for Cdc14
release. To address this possibility, we assayed for Cdc14 release in
a cdc15-2 mad1D rpd3D mutant and observed a complete absence
of release, suggesting that histone deacetylation is necessary for
Cdc14 release (Figure 5B). However, this requirement appears to
be specific to deacetylation by Rpd3, as deletion of Hda1, a related
histone deacetylase that displays overlapping functions with Rpd3
[45], did not show genetic interactions with lte1D and displays only
a very slight Cdc14 release defect (Figure 5A and 5B). Similarly, a
mutant strain deleted for Sir2, the histone deacetylase responsible
for rDNA silencing in yeast, displayed no synthetic growth defect
when combined with lte1D and was still able to release Cdc14 in
the absence of MEN activity (Figure 5A and 5B).
Cdc14 Release Defects of FEAR Pathway and Histone
Modification Mutants Do Not Require the Histone
Deacetylase Sir2
The data above indicate that the loss of Sir2 does not affect the
ability of cells to release Cdc14 in the absence of MEN. However,
recent studies from our laboratory and others have shown that
histone H3 methylation can antagonize the association and
function of Sir2 [46]. In addition, cells lacking Ubp10, an H2B-
K123 deubiquitinating enzyme, display a decrease in Sir2 binding
at the NTS1 region of rDNA where Cdc14 is bound [39]. This
raised the possibility that the Cdc14 release defects that we observe
in histone modification mutants result from increased or altered
localization of Sir2 at rDNA. To address this possibility, we
assayed a cdc15-2 mad1D htb1-K123R htb2-K123R sir2D mutant to
determine whether or not deletion of Sir2 could rescue the Cdc14
release defect of cdc15-2 mad1D htb1-K123R htb2-K123R cells. No
changes in Cdc14 release were observed when the two mutants
were compared (Figure 6A and 6B), suggesting that altered Sir2
function is not responsible for the Cdc14 release phenotype of
htb1-K123R htb2-K123R mutants. Furthermore, deletion of Sir2
did not rescue the Cdc14 release defects of spo12D bns1D or slk19D
mutants, demonstrating that aberrant Sir2 function is not the
cause of the Cdc14 release defects observed in known FEAR
pathway mutants (Figure 6A and 6B).
Discussion
Although typically thought of as a site for transcription of tandem
arrays of rDNA genes, rRNA processing, and ribosome assembly,
the nucleolus plays other critical roles in cellular regulation. The
anchoring of the conserved eukaryotic phosphatase Cdc14 in the
nucleolus is a prominent example of such a function. Despite the
physical association of Cdc14 and its sequestration machinery with
Histone Modifications Required for Cdc14 Release
PLoS Genetics | www.plosgenetics.org 6 August 2009 | Volume 5 | Issue 8 | e1000588nucleolar chromatin, the impact of chromatin modifications on this
mechanism has not been reported previously.
In this study, we provide evidence for a role for the conserved
ubiquitin ligase Bre1 and monoubiquitination of histone H2B in
the early phase of mitotic exit. First, in cells lacking the MEN
component Lte1, we observed that deletion of BRE1 or mutation
of the codon encoding the target lysine in both H2B genes results
in cellular inviability or severe growth defects, respectively. Such a
phenotype is characteristic of mutants in components of the FEAR
network responsible for the early anaphase release of Cdc14.
Second, we found that Bre1 and ubH2B-K123 are indeed
required for full Cdc14 release during early anaphase when the
MEN is inactivated by the cdc15-2 mutant.
Furthermore, we established that this requirement for ubH2B-
K123 in Cdc14 release is dependent on the downstream effects of
ubH2B-K123 on the methylation of H3K4 and H3K79, as strains
unable to be methylated on either residue are also defective for
early anaphase Cdc14 release. We also observed Cdc14 release
Figure 4. Genetic interaction and Cdc14 release profile of histone H3 methylase mutants combined with MEN mutants. (A) Genetic
interactions of set1D, dot1D, set2D, set1D dot1D, and set1D set2D mutations with the lte1D mutation. Strains were assayed as in Figure 2A. (B,C) The
temporal profile of Cdc14 release from nucleolar sequestration is displayed for strains of the indicated genotypes. Time courses were performed as
described in Figure 2C.
doi:10.1371/journal.pgen.1000588.g004
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which was surprising since H3K36 methylation does not require
ubH2B-K123 [47]. Nonetheless, these data demonstrate that all
three of the known methylation marks on histone H3 in S. cerevisiae
play a role in this process. These data may also help to explain the
observation that a haploid H3K4R,36R,79R strain mutated for all
three H3 methylation sites displays an increased population of cells
with 2C DNA content [48].
The requirement for histone modifications in mitotic exit is
most simply explained by the direct modification of nucleolar
chromatin (Figure 7). We demonstrated that the Cdc14 release
defects we observe are not correlated with changes in expression
levels of known Cdc14 release factors, as the transcript and protein
levels of regulators are unchanged or increased in bre1D mutants.
The sole exception is the increase in levels of Cfi1/Net1, which
could potentially cause an increase in Cdc14 sequestration.
However, this increase does not change the levels of Cfi1/Net1
or Fob1 associated with chromatin at the rDNA locus as measured
by ChIP. The presence of both H3K4 and K79 methylation has
been reported at rDNA chromatin by ChIP, consistent with a
direct role for these modifications in affecting rDNA function
[34,35,49,50]. Dot1, the H3K79 methylase, has also been
reported to be present in the nucleolus by microscopy of cycling
cells and spread mitotic nuclei [51]. Lastly, deletion of Ubp10, a
deubiquitinating enzyme for ubH2B-K123, increases the levels of
both meH3K4 and K79 at the NTS1 region, suggesting that
ubH2B-K123 is also present at the site of Cdc14 sequestration and
is able to promote the methylation of H3K4 and K79 at this locus
[39]. These modifications may depend on the transcription of this
region by RNA polymerase II (Pol II), since there is a reported
transcript produced from a promoter in the NTS1 region and Pol
II has been detected in this region by ChIP [50,52,53].
I na d d i t i o nt os h o w i n gt h a th i s tone H2B ubiquitination and
histone H3 methylation are required for efficient Cdc14 release,
we verified the reported genetic interaction of rpd3D and lte1D
[40] and demonstrated defects in Cdc14 release of rpd3D mutants
when MEN activity was inhibited. Unlike histone methylation,
however, the requirement for histone deacetylation in Cdc14
release was specific to deacetylation by Rpd3 and not shared by
other HDACs such as Hda1 and Sir2. These results are in
agreement with expression microarray data showing no signif-
icant overlap between sir2D and rpd3D mutant expression profiles
and the overrepresentation of cell cycle related transcripts in
rpd3D that is not observed in hda1D mutants [45]. The
transcriptional changes of cell cycle genes in rpd3D mutants
suggest a possible indirect transcriptional mechanism for the
Figure 5. Genetic interaction and Cdc14 release profile of histone deacetylase mutants combined with MEN mutants. (A) Genetic
interactions of the sir2D, hda1D, and rpd3D mutations with the lte1D mutation. Strains were assayed as in Figure 2A. (B) Time course analysis. The
temporal profile of Cdc14 release from nucleolar sequestration is displayed for strains of the indicated genotypes. Time courses were performed as
described in Figure 2C.
doi:10.1371/journal.pgen.1000588.g005
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reports linking Rpd3 to rDNA functions a direct role at rDNA
cannot be excluded [54,55].
Although our studies point to a role for histone modifications in
controlling the early anaphase release of Cdc14, understanding the
underlying biochemical mechanisms involved will require further
studies. An appealing possibility is that histone modifications may
serve to maintain a permissive state for mitotic exit regulators to
access the chromatin associated factors Cfi1/Net1 and Fob1 at the
onset of anaphase and to enact the release of Cdc14 (Figure 7).
Surprisingly, our genetic experiments indicate that this require-
ment is independent of the action of the Cdc14-associated histone
deacetylase Sir2 and removal of Sir2 did not bypass the
requirement for histone modifications in Cdc14 release. Potential
candidates whose access to Cfi1/Net1 could be affected by this
alteration of chromatin function include Cdc5 and Clb-Cdk, the
kinases responsible for Cfi/Net1 phosphorylation, and PP2A
Cdc55,
the phosphatase complex that counteracts this phosphorylation.
Recently, Zds1 and Zds2, previously identified to associate with
the chromatin silencing machinery [56], have been shown to play
a role in early anaphase release of Cdc14 and to interact with
PP2A
Cdc55 [20], suggesting another potential mediator for the
histone modification requirement for efficient mitotic exit.
As all of the histone modifications studied here are conserved
from yeast to mammals, it seems possible that their role in
controlling localization of Cdc14 is also conserved. A hint that this
might be the case comes from studies of HUB1, the homolog of
Bre1 in Arabidopsis thaliana. Cells from hub1-1 mutants exhibit an
increased population with 4C DNA content, consistent with a
delay in progression through G2 or mitosis [57]. In addition, while
Cdc14 is not essential for mitotic exit in animal cells, its cell cycle-
regulated association with the nucleolus is remarkably conserved
from yeast to humans [58]. Recently, it was reported that
mammalian cells have adapted the Cdc14 sequestration mecha-
nism to regulate the G2 DNA-damage checkpoint [59]. Given the
emerging role of meH3K79 and other histone modifications in the
DNA damage response [60], it is possible that the Cdc14
regulation by meH3K79 described here is relevant to the function
in metazoans of this conserved histone modification in DNA
damage checkpoint signaling.
More generally, our studies point to a role for histone
modifications in a process involving chromatin but not directly
Figure 6. Sir2 is not responsible for Cdc14 release defects of htb1-K123R htb2-K123R and FEAR network mutants. (A,B) Time course
analysis. The temporal profile of Cdc14 release from nucleolar sequestration is displayed for strains of the indicated genotypes. Time courses were
performed as described in Figure 2C.
doi:10.1371/journal.pgen.1000588.g006
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functional studies have been focused. The nonredundant role for
all three known histone methylations in mitotic exit suggests they
do not function in this context as part of a combinatorial code but
instead may affect chromatin in a similar way to promote the
programmed release of a chromatin bound factor.
Materials and Methods
Yeast Strains and Plasmids
A list of the yeast strains and plasmids used in this paper is found
in Table S1. Knockout strains were generated by homologous
recombination by transforming the parent strain with PCR
products encoding drug or auxotrophic markers flanked by
targeting homology.
Measurement of Genetic Interactions
Genetic interactions of mutants with lte1D mutations were
assayed by sporulation and tetrad dissection of heterozygous
diploids containing a wild type copy of LTE1 on the CEN URA3
pRS316 plasmid (pRS316-LTE1). Spores with the respective
single, double, and triple mutations and the pRS316-LTE1
plasmid were selected for and grown overnight on YPD plates to
increase the population of cells that have lost the plasmid. To assay
for growth of mutants without LTE1, strains were inoculated from
frozen stocks into minimal synthetic defined liquid media lacking
uracil (SD –Ura) and grown overnight to select for pRS316-LTE1,
and diluted into liquid YPD media and grown overnight to allow
for loss of the plasmid. Five-fold dilutions of 1 OD of cells were
made in water and transferred onto plates containing the drug 5-
fluoroorotic acid (5-FOA) to select against cells that still harbor the
URA3-marked plasmid or SD –Ura plates to control for amount of
cells plated. The wild type and lte1D mutants shown for Figure 2,
Figure 4, and Figure 5 are from tetrad dissections of YM2589 and
are representative of the growth of wild type and lte1D mutants
from tetrad dissection of YM3477, YM3463, YM2924, YM3482,
YM3476, and YM3447.
Cell Cycle Time Course for Cdc14 Localization
cdc15-2 strains were inoculated from frozen stocks and grown
overnight at 25uC in YPD medium and then diluted and grown an
additional night until saturation. Cultures were diluted into 25 ml
of YPD at room temperature and grown for at least one doubling
until OD 0.2 at 25uC. Alpha-factor (25 ml of 10 mg/ml) was
added twice to each culture for a total of 2.5 hrs to arrest cells in
G1. To release cells into the cell cycle, cells were first collected on
nitrocellulose filters and washed with 5625 ml of YPD to
eliminate residual alpha factor. Cells were then resuspended in
25 mL of YPD pre-warmed to 37uC at the 0 min timepoint to
inactivate the cdc15-2 gene product and incubated until time
course completion. 1 ml samples were collected at each timepoint
and processed as described below. Time courses with CDC15
strains were performed as above except cells were resuspended at
timepoint 0 min in 25uC YPD media and incubated at 25uC
during the time course.
Indirect Immunofluorescence
Samples collected from time course are resuspended in 1 ml
Buffer KP+formaldehyde (90 mM potassium phosphate pH 6.4,
3.7% formaldehyde) and split into two 500 ml fractions. Fraction
#1 (for Cdc14-HA localization) is fixed by incubation at 30uC for
10 min (mixed on BD Clay Adams Nutator). Fraction #2 (for
spindle visualization) is fixed overnight at 4uC without mixing
(overnight fixation increases spindle signal). Both samples are
washed 36 after fixation with 1 ml of Buffer KP (100 mM
potassium phosphate pH 6.4) and once with 1 ml Buffer KPS
(100 mM K2HPO4, 1.2 M sorbitol, 36 mM citric acid, pH 5.9).
Samples are resuspended in 250 ml of Buffer KPS and stored
overnight at 220uC. Samples are defrosted and digested by
addition of 2 ml of 10 mg/ml Zymolyase 100T (#120493,
Seikagaku America) and 20 ml of Glusulase (#NEE154001EA,
PerkinElmer) at 30uC with nutation (Fraction #1 samples digested
15 min while Fraction #2 samples digested 30 min). Digested cells
are washed once with Buffer KPS (after digestion spin at
2000 rpm) and resuspended in ,20–40 ml Buffer KPS depending
on size of pellet. 10 ml of cells are applied for 2 min to glass slides
with wells (ER-267W, Erie Scientific) that have been pre-coated
with 0.1% poly-L-lysine for 5 min. Cells are aspirated and slides
are plunged sequentially into cold methanol for 3 min and 10 sec
into cold acetone (methanol and acetone were stored at 220uC).
Wells were washed twice with BSA-PBS (16PBS with 10 mg/ml
BSA) and incubated with 20 ml of either anti-HA (MMS-101R,
Covance, diluted 1:150) or anti-tubulin (NB100-1639, Novus,
diluted 1:250) antibody in BSA-PBS for 1.5 hrs in a humid
chamber. Wells were washed 56 with BSA-PBS and incubated
with 20 ml of either anti-mouse TRITC conjugated secondary or
anti-rat FITC conjugated secondary antibody (715-025-150, 712-
095-150, Jackson ImmunoReseach, both diluted 1:1000) in BSA-
PBS for 2 hrs in a humid chamber. Wells are washed 56 with
BSA-PBS and mounted in mounting media (1 mg/mL phenyl-
enediamine, 40 mM K2HPO, 10 mM KH2PO4, 150 mM NaCl,
0.1% NaN3,5 0 mg/mL DAPI, 5% vectashield, 90% glycerol,
pH 8). Slides are analyzed with the Zeiss Axiovert 200 M inverted
microscope and images were analyzed with AxioVision 4.6
software. For spindle measurements, slides were analyzed with
the DeltaVision Spectris deconvolution microscope and images
were analyzed using the softWoRx software suite.
Figure 7. Nonredundant roles for histone modifications in
promoting early anaphase release of Cdc14. This model proposes
that the three known histone methylations present in S. cerevisiae
function nonredundantly to change nucleolar chromatin structure and
permit FEAR pathway signaling.
doi:10.1371/journal.pgen.1000588.g007
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Analysis (RT–QPCR)
Saturated overnight cultures are diluted to OD 0.05 in 25 mL
of YPD and grown at 30uC until OD 0.4–0.5. Cells are washed
with ice-cold water and snap-frozen. Pellets are resuspended in
1 ml of TRIzol (15596-026, Invitrogen) and zirconia/silica beads
were added. Cells were disrupted in a Mini-Beadbeater-8 by two
cycles of disruption at full power for 2.5 min, cooling on ice for
2.5 min between each cycle. Lysates were clarified by centrifuga-
tion (13,500 rpm for 10 min at 4uC) and transferred to a fresh
tube. 200 ml chloroform was added, vortexed, incubated for
10 min at room temperature, and spun at 13,500 rpm for 10 min
at 4uC. Aqueous phase was treated with 500 ml chloroform as
above. 500 ml isopropanol was added to the aqueous phase,
incubated for 15 min at 4uC, and spun at 13,500 rpm for 10 min
at 4uC. Pellets are washed with 1 ml 75% ethanol, dried by speed
vac, resuspended in 100 ml water, and incubated at 55uC for 1 hr.
40 mg of total RNA was diluted in 72 ml of water per replicate
(each RNA sample was treated in triplicate) and treated with
TURBO DNA-free kit (1907, Ambion). Approximately 15 mgo f
total RNA was used for each RT and minus RT 50 ml reaction
(50 mM Tris-HCl pH 8.4, 75 mM KCl, 0.5 mg/mld T 20N
oligonucleotide). Reactions were incubated for 10 min at 70uC
and 10 min on ice. 50 ml enzyme/dNTP mix (50 mM Tris-HCl
pH 8.4, 75 mM KCl, 6 mM MgCl2, 20 mM DTT, 1 mM dNTP,
26RT) was added to the reactions and were incubated overnight
at 42uC. Samples were treated with 2 ml of 0.5 M EDTA,
vortexed, 10 ml of 1 N NaOH was added and incubated for
10 min at 65uC, and subsequently neutralized with 10 mlo f1N
HCl. cDNA was purified using Zymo DNA Clean & Concentrator
columns (D4004) and samples were diluted 1:100 for qPCR
analysis. Sequences of primers used available upon request.
Western Blotting
This protocol was modified from [61]. Cells (6 OD) are
collected at ,0.7–0.8 OD after growth for at least two doublings.
Cell pellets were washed with ice-cold water and flash-frozen with
liquid N2 and stored at 280uC. Frozen cell pellets were
resuspended in 240 ml of Sample Buffer (50 mM Tris pH 7.5,
5 mM EDTA, 5% SDS, 10% glycerol, 0.5% 2-mercaptoethanol,
1:100 dilution of Phosphatase Inhibitor Cocktail 1 and 2 [P2850
and P5726, Sigma], 1:260 dilution of Protease Inhibitor Cocktail
[P8215, Sigma], 100 mM PMSF, bromophenol blue for color)
preheated to 100uC and incubated in 100uC heat block for 3–
5 min. Approximately 100 ml of zirconia/silica beads were added
to each tube and cells were lysed by beadbeating at full power with
Mini-Beadbeater-8 (#693, Bio Spec) for 3 min. Tubes are
centrifuged briefly and incubated at 100uC for 3 min, vortexed,
and centrifuged at 14K rpm for 10 min. 10 ml of supernatant is
loaded and run on 4–15% Tris-HCI SDS-PAGE gel (#3450029,
Bio-Rad) and transferred to nitrocellulose for 16 hr (25 V at 4uC)
in SDS transfer buffer (20 mM Tris base, 150 mM glycine,
0.375% SDS, 20% methanol). Blots are cut below a 28 kDa
marker in order to simultaneously probe for different primaries
and are blocked for 30 min with TBST (10 mM Tris-HCl pH 8.0,
150 mM NaCl, 0.05% Tween 20)+5% milk, incubated with either
anti-HA (diluted 1:1500), anti-myc 9E10 (sc-40, Santa Cruz,
diluted 1:2000), or anti-dimeH3K4 (#07-030, Upstate, diluted
1:1000) in TBST+5% milk for 1 hr, washed 56 for 5 min with
TBST, incubated with either anti-mouse or rabbit HRP secondary
(170-6515, 170-6516, Bio-Rad, diluted 1:5000) in TBST+5% milk
for 30 min, and washed with 56for 5 min with TBST. Blots are
visualized by enhanced chemiluminescence substrate (#34080,
Thermo Scientific) and are stripped and reprobed by anti-Pgk1
antibody to control for loading (A6457, Molecular Probes, diluted
1:10000).
Chromatin Immunoprecipitation (ChIP)
Cells were grown to mid-log phase (OD ,0.4). 50 ml of cells
were fixed with 1% formaldehyde at room temperature for
15 min. Glycine was added to a final concentration of 125 mM
and samples were incubated at room temperature for 5 min. Cells
were washed twice with TBS (20 mM Tris-HCl pH 7.6, 150 mM
NaCl), collected by centrifugation and snap-frozen. Pellets were
resuspended in 500 ml of lysis buffer (50 mM HEPES pH 7.5,
140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium
deoxycholate) with 1:260 Sigma Protease Inhibitor Cocktail) and
zirconia/silica beads were added. Cells were disrupted in a Mini-
Beadbeater-8 by five cycles of disruption at full power for 1 min,
cooling on ice for 2 min between each cycle. The lysate was
collected. The pellet containing chromatin was separated by
centrifugation and resuspended in 300 ml lysis buffer. Sonication
was performed using a waterbath sonicator (Bioruptor) set to cycle
at 30 sec on and 1 min off for 30 min. Cell debris was removed by
centrifugation at 14,000 rpm for 10 min. 1 ml of anti-HA antibody
was added to each sample and the mixture was nutated at 4uC for
2 hr. Protein G Sepharose (#17-0618-01, GE Healthcare) was
washed 36in PBS and 26in lysis buffer. 20 ml of washed beads
were added to each sample. After 1.5 hr at 4uC the beads were
washed 26with lysis buffer, 26with high salt lysis buffer (50 mM
HEPES pH 7.5, 500 mM NaCl, 1 mM EDTA, 1% Triton X-100,
0.1% sodium deoxycholate), 26 with wash buffer (10 mM Tris-
HCl pH 8.0, 250 mM LiCl, 0.5% NP-40, 0.5% sodium
deoxycholate, 1 mM EDTA) and once with TE pH 8.0. 100 ml
of elution buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 1%
SDS) was added and the samples were incubated at 65uC for
15 min. The eluate was collected by centrifugation. The beads
were washed with TE+0.67% SDS+proteinase K and the
supernatant was added to the eluate from the previous step and
incubated at 65uC overnight. DNA was purified using Qiagen
PCR purification columns. RNAse A was added to the purified
DNA and the samples were incubated at 37uC for 1 hr. Samples
were subjected to quantitative PCR analysis (primers used were
from [62]).
FACS Analysis
2.5 ml cells were collected in 10 min intervals after alpha-factor
arrest as described above. Cells were pelleted and resuspended in
5 ml of 70% ethanol to fix overnight at 4uC. Samples are washed
twice in 750 ml of 50 mM Tris-HCl pH 8 with 5 mM EDTA.
Cells are resuspended in 500 ml of RNase A solution (2 mg/ml
RNase [R5503, Sigma], 50 mM Tris-Cl pH 8, 5 mM EDTA
previously boiled for 15 min and cooled to room temperature on
the bench) and incubated for 4 hours at 37uC. Cells are pelleted,
resuspended in 200 ml of Pepsin solution (5 mg/ml Pepsin [P7000,
Sigma] in 55 mM HCl), and incubated for 20 min at 37uC.
Samples are washed once in 750 ml of 50 mM Tris-HCl pH 7.5
with 5 mM EDTA and resuspended in 500 ml of the same buffer.
50 ml of cells added to 1 mL of Sytox solution (1 mM Sytox Green
[S7020, Molecular Probes], 50 mM Tris-HCl pH 7.5, 5 mM
EDTA) and are sonicated to break up cell clumps (Branson 450
Sonifier). Samples are incubated overnight at 4uC and analyzed
the next day by flow cytometry with the BD FACSCalibur system.
Supporting Information
Figure S1 Synthetic lethal interactions between bre1D, rad6D,
and lge1D can be suppressed by deletion of BUB2. Diploid strains
Histone Modifications Required for Cdc14 Release
PLoS Genetics | www.plosgenetics.org 11 August 2009 | Volume 5 | Issue 8 | e1000588heterozygous for lte1D, bub2D, and either the bre1D, rad6D or lge1D
mutations are sporulated and analyzed by tetrad dissection. The
red circles refer to spores that are predicted by the genotypes of the
other spores in the tetrad to be double mutants of lte1D with bre1D,
rad6D,o rlge1D. The blue circles refer to spores that are triple
mutants for lte1D and bub2D in combination with bre1D, rad6D,
and lge1D. Spores that are missing without a red circle are
predicted to be lte1D single mutants, which appear to have
sporadic viability or germination issues.
Found at: doi:10.1371/journal.pgen.1000588.s001 (8.89 MB TIF)
Figure S2 Cdc14 release profile of cdc15-2 mad1D and cdc15-2
mad1D bre1D mutants by measuring spindle length. The profile of
Cdc14 release from nucleolar sequestration is displayed for cdc15-2
mad1D and cdc15-2 mad1D bre1D mutants as a function of the
spindle length of each individual cell. Alpha-factor arrested cells
are released into YPD media at 37uC to inactivate the cdc15-2
mutant gene product and the 90 minute (for cdc15-2 mad1D) and
110 minute (for cdc15-2 mad1D bre1D) timepoints are processed for
indirect immunofluorescence as described in Figure 2B. Approx-
imately 125–150 cells were quantified for each strain for spindle
length measurements and for full or partial release of Cdc14-HA.
Found at: doi:10.1371/journal.pgen.1000588.s002 (0.52 MB TIF)
Figure S3 Cell cycle progression of cdc15-2 mad1D and cdc15-2
mad1D bre1D mutants. The DNA content profile of cdc15-2 mad1D
and cdc15-2 mad1D bre1D mutants released from alpha-factor arrest
are measured by flow cytometry. Alpha-factor arrested cells are
released into YPD media at 37uC to inactivate the cdc15-2 mutant
gene product. Samples taken at 10 minute intervals are fixed with
70% ethanol. 20,000 cells were measured for each timepoint for
1C or 2C DNA content by measurement of fluorescence from
SYTOX incorporation. Profiles labeled in blue are timepoints that
are undergoing transition from G1 to G2 content.
Found at: doi:10.1371/journal.pgen.1000588.s003 (0.93 MB TIF)
Table S1 Strains and plasmids.
Found at: doi:10.1371/journal.pgen.1000588.s004 (0.10 MB
DOC)
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